Monitoring Apoptotic Activity of Silver(I) Metallodrugs Containing Mefenamic Acid and Mitochondriotropic Agents in Artificial Breast Tumor Tissues
ChemMedChem · 2025
DOI: 10.1002/cmdc.202500414 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Christina N Banti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biological Inorganic Chemistry laboratory, Department of Chemistry, University of Ioannina, 45110, Ioannina, Greece. Hauptthemen laut MEDLINE: Apoptosis, Antineoplastic Agents, Silver, Breast Neoplasms. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Social Fund.
Abstract (Originalsprache)
The anticancer potential of silver(I) metallodrugs incorporating mefenamic acid and mitochondriotropic agents in 3D spheroid models of hormone‐dependent breast cancer cells (MCF‐7) is investigated within this work. The compounds, previously evaluated in 2D cultures, demonstrated potent antiproliferative activity with IC 50 values ranging from 1.01 to 5.20 μM, significantly outperforming cisplatin. Here, 3D spheroids are employed to simulate the tumor microenvironment, assessing drug efficacy through morphological changes and apoptosis rates. Compounds 1–4 exhibited dose‐ and time‐dependent reductions in spheroid compactness and sphericity, with compound 2 achieving complete loss of compactness (0%) and sphericity (2%) at 10 μM after 48 h. Apoptotic activity is also significantly higher in 3D spheroids treated with these compounds with respect to their control (25.8%−41.4%), in contrast to cisplatin (24.4%) and untreated cells (8.0%). The results validate the superior efficacy of silver(I) complexes in disrupting tumor integrity and inducing apoptosis. This study underscores the potential of 3D spheroid models for preclinical evaluation and highlights silver(I) metallodrugs as promising candidates for breast cancer therapy. Future research should focus on in vivo validation to further explore their therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biological Inorganic Chemistry laboratory, Department of Chemistry, University of Ioannina, 45110, Ioannina, Greece.
- Institute of Materials Science and Computing, University Research Center of Ioannina (URCI), 45110, Ioannina, Greece.
ORCID-Profile: Christina N Banti, Sotiris K Hadjikakou
Förderung
- European Social Fund
Zitieren
APA
Banti, C. N., & Hadjikakou, S. K. (2025). Monitoring Apoptotic Activity of Silver(I) Metallodrugs Containing Mefenamic Acid and Mitochondriotropic Agents in Artificial Breast Tumor Tissues. ChemMedChem. https://doi.org/10.1002/cmdc.202500414
Vancouver
Banti CN, Hadjikakou SK. Monitoring Apoptotic Activity of Silver(I) Metallodrugs Containing Mefenamic Acid and Mitochondriotropic Agents in Artificial Breast Tumor Tissues. ChemMedChem. 2025. doi:10.1002/cmdc.202500414
BibTeX
@article{Banti2025,
author = {Banti, Christina N and Hadjikakou, Sotiris K},
title = {Monitoring Apoptotic Activity of Silver(I) Metallodrugs Containing Mefenamic Acid and Mitochondriotropic Agents in Artificial Breast Tumor Tissues},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202500414}
}
EUVIMED